and Analysis for 2018 To : Director and the President The Stock Exchange of Thailand Summary of the Company’s Financial Position and Operating Result for the 3 and 9 month period ended 30 Sep. 2018
percent in 9-months period of 2019. Thus, the details of the Company group can be described as follows: Summary of Income Statement Highlights of Performance in Q3/2019 and 9-month of 2019 9 month’s total
share-Owners of the Company (0.10 ) (0.07 ) (0.03) (40.56%) Attributable to Owners of the Company (84.18) (59.89) (24.29 ) (40.56%) Non-controlling interests - - - - 1. Operating revenue In summary
of the Company and its subsidiaries for year 2019 which has been audited by auditor are as follows: Table 1: Financial Summary for the year 2019 Unit: Million Baht 2019 2018 Increase (Decrease
on dissolution of Solvay Biochemicals (Taixing) Limited amounting to 89 MB from other comprehensive income to the profit of the year 2018. Summary of Performance For the year 2019, the Company and its
office building business 337 384 (47) (12) Other income 269 261 8 3 Total revenues 10,949 16,148 (5,199) (32) In summary, the Company and its subsidiaries generated total revenues for the year ended 2019
co from Bt244 t 4.7GB/data su AIS Fibre cont increased to B higher speed p Summary d to focus on g data leadersh gh quality subsc ed existing qua 22,843mn wer strengthen attractive
Management Discussion and Analysis as follows : FINANCIAL SUMMARY 31.12.15 31.12.16 30.06.17 FINANCIAL POSITION (MILLION BAHT) Current Assets 1,246 1,228 1,279 Total Assets 1,378 1,361 1,407 Current
at the previous year and increase loss by 17% compare to Q1/16. 2 2. Financial Performance Summary – by business Revenues by business Q2/2017 Q2/2016 YoY THB’000 THB’000 Distributor of medical devices
Management Discussion and Analysis as follows : FINANCIAL SUMMARY 31.12.15 31.12.16 30.09.17 FINANCIAL POSITION (MILLION BAHT) Current Assets 1,246 1,228 1,165 Total Assets 1,378 1,361 1,290 Current